FCM
GCVRZ

Farmstead Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Farmstead Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-460,400
Closed -$88K – 11
2015
Q3 		$88K Hold
460,400
– – 0.1% 8
2015
Q2 		$322K Hold
460,400
– – 0.16% 8
2015
Q1 		$312K Hold
460,400
– – 0.13% 8
2014
Q4 		$364K Buy
+460,400
New +$314K 0.22% 7

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Farmstead Capital Management's GCVRZ Position: Q4 2015 in Review

Farmstead Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 460,400 shares — an estimated $88K sold.

Farmstead Capital Management first reported a position in GCVRZ in Q4 2014 and held it in 4 quarters. The position peaked at $364K in Q4 2014. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Farmstead Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Farmstead Capital Management sold 460,400 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $88K.
  • Farmstead Capital Management first reported a position in Sanofi Contingent Value Rights in Q4 2014 and held it in 4 quarters.
  • Farmstead Capital Management's Sanofi Contingent Value Rights position peaked at $364K in Q4 2014.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Farmstead Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.